---
$id: https://graph.org.ai/products/commodity/51141515
$type: Product
source: UNSPSC
code: "51141515"
title: "Ethotoin"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ethotoin

**UNSPSC Code**: 51141515
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C11H12N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46QG38NC4U, chemically known as 2,4-imidazolidinedione, 3-ethyl-5-phenyl- but generally known as ethotoin, which bears US NIH Compound Identifier 3292. European Medicines Agency schedules Ethotoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07283MIG. The term ETHOTOIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules ethotoin in its Anatomical Therapeutic Chemical (ATC) Classification. ETHOTOIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ethotoin under HS 29332100 and SITC 51572. As of Q4 2014, ETHOTOIN remains the US FDA Preferred Term for this commodity. Ethotoin bears US NLM identifiers UMLS ID C0015046 and NCI Concept Code C47524. SMILES: CCN1C(=O)C(NC1=O)C2=CC=CC=C2.

